Ex-Takeda Exec Settles SEC Insider Trading Claims

Law360, New York (February 9, 2012, 3:07 PM EST) -- A former Takeda Pharmaceuticals International Inc. executive agreed Thursday to pay $136,000 to settle a U.S. Securities and Exchange Commission suit alleging he profited from insider trading before a major Takeda acquisition.

The SEC filed and settled the suit alleging Brent C. Bankosky, a former senior director in Takeda’s U.S. business development group, used nonpublic information to place personal trades before Takeda purchased Millennium Pharmaceuticals Inc. for $8.8 billion in April 2008. Bankosky also traded in advance of a March 2008 strategic alliance between Takeda and...
To view the full article, register now.